Leading acne vulgaris companies, including Ortho Dermatologics, Bausch Health, Galderma Labs, Timber Pharmaceuticals, BioPharmX, Kintor Pharma, Botanix Pharmaceuticals, Dermata Therapeutics, AstraZeneca, Novartis Pharmaceuticals, UCB Pharma, Incyte Corporation and others, are aggressively pursuing the treatment space. Acne vulgaris treatment market (Albany, USA) DelveInsight's extensive report,...

  Diabetic foot ulcers (DFUs) are one of the most common and serious complications in individuals suffering from diabetes. As the global burden of diabetes increases, so does the prevalence of DFUs, leading to significant challenges in healthcare. According to the American Diabetes Association, between 19% to 34% of diabetic patients are likely to develop foot ulcers in their lifetime....

In the landscape of biomedical innovation, microneedle technology has emerged as a transformative platform for advancing drug delivery, vaccine research, and diagnostic tool development. By combining microfabrication expertise with the evolving needs of pharmaceutical and biotech research, microneedles offer a minimally invasive, efficient approach to enhance transdermal delivery and...

The New European Patent Law for Medical Innovation is reshaping the way biomedical technologies are protected and commercialized across Europe. With the launch of the Unified Patent Court (UPC) and the Unitary Patent (UP) system, the medical innovation landscape is entering a new era that aligns legal protections with the needs of cutting-edge scientific advancements. For companies and...

      The global pharmaceutical industry stands at the forefront of medical innovation, developing breakthrough therapies that address previously untreatable conditions and improve patient outcomes worldwide. Behind this remarkable progress lies a sophisticated network of specialized organizations that provide essential support for drug development and manufacturing activities....

Gene therapy is revolutionizing the medical world, offering hope for treating previously incurable diseases by addressing issues at their genetic roots. The field is evolving rapidly, with innovations that promise to reshape healthcare. This article explores the latest trends in gene therapy and how companies like Avenga contribute to advancing the industry by providing tailored software and...